AKAP9 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 3.13380432714894E-11 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
7.11359970928527E-10 |
Normal-vs-Stage2 |
3.924600E-03 |
Normal-vs-Stage3 |
1.70174985214544E-12 |
Normal-vs-Stage4 |
1.72595271408227E-12 |
Stage1-vs-Stage2 |
2.623400E-01 |
Stage1-vs-Stage3 |
9.71159999999527E-05 |
Stage1-vs-Stage4 |
1.828780E-04 |
Stage2-vs-Stage3 |
1.597600E-02 |
Stage2-vs-Stage4 |
1.666320E-02 |
Stage3-vs-Stage4 |
9.862800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
3.76110254052264E-11 |
Normal-vs-AfricanAmerican |
1.28399957333158E-10 |
Normal-vs-Asian |
4.038500E-02 |
Caucasian-vs-AfricanAmerican |
5.909000E-01 |
Caucasian-vs-Asian |
5.277400E-01 |
AfricanAmerican-vs-Asian |
2.999000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.53299595240242E-11 |
Normal-vs-Female |
7.81874565092266E-12 |
Male-vs-Female |
3.875600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
5.06419994827922E-09 |
Normal-vs-Age(41-60Yrs) |
3.86649601225031E-11 |
Normal-vs-Age(61-80Yrs) |
6.22824014584467E-12 |
Normal-vs-Age(81-100Yrs) |
2.03179995050817E-09 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.706160E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.596400E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.653400E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.004300E-02 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.087560E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.328600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
1.061860E-02 |
Normal-vs-Grade 2 |
1.19010001853326E-09 |
Normal-vs-Grade 3 |
5.95845595086075E-12 |
Normal-vs-Grade 4 |
1.62547753035369E-12 |
Grade 1-vs-Grade 2 |
1.010600E-01 |
Grade 1-vs-Grade 3 |
1.075600E-02 |
Grade 1-vs-Grade 4 |
1.86589999995324E-06 |
Grade 2-vs-Grade 3 |
2.499800E-02 |
Grade 2-vs-Grade 4 |
4.74129999705752E-08 |
Grade 3-vs-Grade 4 |
5.169900E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
5.99710003879039E-09 |
Normal-vs-ccB subtype |
5.36115596361242E-12 |
ccA subtype-vs-ccB subtype |
2.357700E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.96760052695311E-10 |
Normal-vs-N1 |
7.70060015753415E-10 |
N0-vs-N1 |
1.435640E-02 |
|
|